Related Experiment Video
Updated: Aug 14, 2026
07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Localization of metastases from medullary thyroid carcinoma using different methods
Henry Ford Hospital Medical Journal
|January 1, 1989
Summary
131I anti-CEA antibody scanning shows promise for detecting recurrent medullary thyroid carcinoma (MTC). This method appears more sensitive than 131I MIBG or CT scans in identifying MTC recurrences.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiology
Background:
- Recurrent medullary thyroid carcinoma (MTC) poses a diagnostic challenge.
- Accurate localization of recurrent MTC is crucial for effective patient management.
Purpose of the Study:
- To evaluate and compare the efficiency of three noninvasive imaging methods for detecting recurrent medullary thyroid carcinoma.
- To identify the most sensitive method for MTC recurrence localization.
Main Methods:
- Analysis of three noninvasive methods: 131I anti-carcinoembryonic antigen (anti-CEA) antibody, 131I meta-iodo-benzylguanidine (MIBG), and computed tomography (CT).
- Study included nine patients with biochemical evidence of recurrent MTC and one patient in remission.
- All patients underwent imaging with the three specified modalities.
Main Results:
- Three out of ten patients had negative results across all three imaging methods.
- Seven patients showed abnormal uptake with 131I anti-CEA antibody.
- Only two patients had corresponding CT findings, and one had 131I MIBG uptake.
Conclusions:
- 131I anti-CEA antibody scanning demonstrated higher sensitivity in localizing recurrent MTC compared to 131I MIBG and CT.
- 131I anti-CEA scanning may be the most effective noninvasive tool for detecting MTC recurrences.
